Trial intelligence / Profile preview

Erythromycin versus nasogastric tube lavage to improve endoscopic visualization in upper GI bleeding

2010-024309-11Phase 3Terminated

Sponsor
JOSEP MARIA BOTARGUES BOTÉ
Start
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of erythromycin in upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by JOSEP MARIA BOTARGUES BOTÉ. Primary endpoint: Endoscopic visual quality. Started Dec 2010; status: terminated.

02

Drugs

erythromycin
03

Conditions

upper gastrointestinal bleeding (UGIB)

Beyond the preview

Go deeper on 2010-024309-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-024309-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call